Dave Kuo
Personalreferent bei PARDES BIOSCIENCES, INC.
Profil
Dave Kuo is currently the Senior Vice President of Human Resources at Pardes Biosciences, Inc. He previously worked as the Head of Human Resources and Information Technology at CV Therapeutics, Inc. Mr. Kuo received his undergraduate degree from the University of California.
Aktive Positionen von Dave Kuo
| Unternehmen | Position | Beginn |
|---|---|---|
| PARDES BIOSCIENCES, INC. | Personalreferent | - |
Ehemalige bekannte Positionen von Dave Kuo
| Unternehmen | Position | Ende |
|---|---|---|
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Technik-/Wissenschafts-/F&E-Leiter | 15.12.2016 |
Ausbildung von Dave Kuo
| University of California | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
